Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The design of this study is to conduct a comprehensive safety evaluation of the pulmonary
hemodynamic effects of Optison. The study is being conducted in subjects referred for cardiac
catheterization for clinical reasons.